Max Robotics — Global Service Robot Directory + US Certification

About

Graham Hale is a leading researcher in prostate cancer imaging and surgical innovation, with a focus on improving preoperative staging and treatment outcomes. His most impactful contribution is the development of a novel MRI grading system for assessing the risk of extraprostatic extension (EPE) of prostate cancer, published in 2019 and cited over 238 times—a testament to its clinical significance. This system provides urologists and radiologists with a standardized, noninvasive tool to predict tumor spread, directly informing surgical planning for robotic-assisted radical prostatectomy. Hale also pioneers the integration of virtual reality (VR) into surgical navigation, creating a multiparametric MRI-based VR tool that enhances precision during robotic prostatectomies. His work extends to evaluating the effects of neoadjuvant therapies like antiandrogen and androgen deprivation therapy on MRI staging, as well as measuring patient-reported quality of life post-surgery. By bridging advanced imaging, emerging technologies, and patient-centered outcomes, Hale’s research has shaped modern prostate cancer management, offering surgeons clearer roadmaps and men better-informed treatment decisions.